Merz Revenue. Merz Pharma GmbH Co. Main Germany District Court of Frankfurt HRB 54072.
Merz Pharma Profile and History. Merz Pharma GmbH Co. EBIT decline The decreased license income of the Alzheimers drug Memantine is the main reason for the decline in earnings before interest and tax EBIT.
Merz Pharmas headquarters are in Eckenheimer Landstraße 100 Frankfurt Hessen 60318 Germany.
Merzs global revenue growth of 68 percent was driven in part by 17 percent year-over-year growth in the aesthetics business. Merz aesthetics earns great place to work certification and named one of the healthiest employers of the triangle. Merz Pharmas revenue is 1 Billion. It is classified as operating in the Drugs Druggists Sundries Merchant Wholesalers industry.